Efficacy of Angoembolization on post PCNL persistent Hematuria

evaluating the efficacy of transcatheter angioembolization for renal trauma following Percutaneous Nephrolithotomy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230715058782N1

Enrollment

Registered

2023-08-05

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

injury of renal blood vessels post PCNL. Injury of renal blood vessels

Interventions

Intervention group: Patient who underwent PCNL and suffer from persistent severe hematuria needing transfusion and patient with delayed hematuria without proper response to conservative treatments are

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Persistent Hematuria after PCNL Hemoglobin drop needing transfusion Delayed persistent hematuria

Exclusion criteria

Exclusion criteria: hypotension allergy to iodine contrast coagulopathy contraindication for iodine contrast patient refusal

Design outcomes

Primary

Measure	Time frame
Hematuria cessation. Timepoint: daily control after angioembolization. Method of measurement: urine appearance.;Serum creatinine. Timepoint: before and 2days after angioembolization. Method of measurement: laboratory.;Hemoglobin. Timepoint: before and daily after angioembolization. Method of measurement: Laboratory.;Packed RBC need for hemodynamic stability. Timepoint: before and after angioembolization. Method of measurement: transfused Packed cell.;Angiographic complications. Timepoint: After angioembolization. Method of measurement: complications related to angioembolization detected by sonography.;Need to operation for bleeding control. Timepoint: daily after angioembolization. Method of measurement: Operation for control of hematuria.	—

Measure

Time frame

Hematuria cessation. Timepoint: daily control after angioembolization. Method of measurement: urine appearance.;Serum creatinine. Timepoint: before and 2days after angioembolization. Method of measurement: laboratory.;Hemoglobin. Timepoint: before and daily after angioembolization. Method of measurement: Laboratory.;Packed RBC need for hemodynamic stability. Timepoint: before and after angioembolization. Method of measurement: transfused Packed cell.;Angiographic complications. Timepoint: After angioembolization. Method of measurement: complications related to angioembolization detected by sonography.;Need to operation for bleeding control. Timepoint: daily after angioembolization. Method of measurement: Operation for control of hematuria.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ashouri

Tehran University of Medical Sciences

m-ashouri@tums.ac.ir+98 21 6119 2606

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026